Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease

Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition

Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982

Steatohepatitis: A tale of two “hits”?

Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285

Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity

Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604

The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM

DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456

Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes

Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321

Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes

Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193

Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference

Neuschwander‐Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,166

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078

Molecular mediators of hepatic steatosis and liver injury

Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772

In an Ovine Model of Polycystic Ovary Syndrome (PCOS) Prenatal Androgens Suppress Female Fetal Renal Gluconeogenesis

Connolly, F., Rae, M. T., Späth, K., Boswell, L., McNeilly, A. S., & Duncan, W. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132113 · Cited by 15

Limitations of detection of anaplerosis and pyruvate cycling from metabolism of [1-13C] acetate

Burgess, S. C., Merritt, M. E., Jones, J. G., Browning, J. D., Sherry, A. D., & Malloy, C. R. (2015) · Nature Medicine · doi:10.1038/nm.3789 · Cited by 15

Energy metabolism: An emerging therapeutic frontier in liver fibrosis

Irshad, I., Alqahtani, S. A., Ikejima, K., Yu, M., Romero‐Gómez, M., & Eslam, M. (2025) · Annals of Hepatology · doi:10.1016/j.aohep.2025.101896 · Cited by 14

Oral combined contraceptives induce liver mitochondrial reactive oxygen species and whole‐body metabolic adaptations in female mice

Fuller, K. N. Z., McCoin, C. S., Stierwalt, H. D., Allen, J., Gandhi, S., Perry, C. G. R., Jambal, P., Shankar, K., & Thyfault, J. P. (2022) · The Journal of Physiology · doi:10.1113/jp283733 · Cited by 17

Protective Effects of Lactobacillus gasseri against High-Cholesterol Diet-Induced Fatty Liver and Regulation of Host Gene Expression Profiles

He, T., Lykov, N., Luo, X., Wang, H., Du, Z., Chen, Z., Chen, S., Zhu, L., Zhao, Y., & Tzeng, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032053 · Cited by 15

Hepatokine ITIH3 protects against hepatic steatosis by downregulating mitochondrial bioenergetics and de novo lipogenesis

Talari, N. K., Mattam, U., Kamińska, D., Sotomayor-Rodriguez, I., Rahman, A. P., Péterfy, M., Pajukanta, P., Pihlajamäki, J., & Krishnan, K. C. (2024) · iScience · doi:10.1016/j.isci.2024.109709 · Cited by 16

tcaSIM: A Simulation Program for Optimal Design of 13C Tracer Experiments for Analysis of Metabolic Flux by NMR and Mass Spectroscopy

Alger, J. R., Sherry, A. D., & Malloy, C. R. (2018) · Current Metabolomics · doi:10.2174/2213235x07666181219115856 · Cited by 15

Astaxanthin inhibits the reduction of glycolysis during the activation of hepatic stellate cells

Bae, M., Lee, Y., Pham, T. X., Hu, S., Park, Y., & Lee, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117926 · Cited by 13

Loss of Acot12 contributes to NAFLD independent of lipolysis of adipose tissue

Park, S., Song, J., Baek, I., Jang, K. Y., Han, C. Y., Jun, D. W., Kim, P. K., Raught, B., & Jin, E. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00648-1 · Cited by 14

Multi-omics-based label-free metabolic flux inference reveals obesity-associated dysregulatory mechanisms in liver glucose metabolism

Uematsu, S., Ohno, S., Tanaka, K. Y., Hatano, A., Kokaji, T., Ito, Y., Kubota, H., Hironaka, K., Suzuki, Y., Matsumoto, M., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103787 · Cited by 13

Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes

Johansen, M. L., Schou, M., Rasmussen, J., Rossignol, P., Holm, M. R., Chabanova, E., Dela, F., Faber, J. O., & Kistorp, C. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.11.003 · Cited by 14

Probing hepatic metabolism of [2-13C]dihydroxyacetone in vivo with 1H-decoupled hyperpolarized 13C-MR

Marco‐Rius, I., Wright, A. J., Hu, D., Savic, D., Miller, J. J. J. J., Timm, K. N., Tyler, D. J., Brindle, K. M., & Comment, A. (2020) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-020-00884-y · Cited by 14

Tirzepatide, a dual GIP/GLP-1 receptor agonist, alleviates metabolic dysfunction-associated steatotic liver disease by reducing the expression of CD36 and OBP2A

Li, Y., Sun, W., Liu, H., & Ruan, X. Z. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101761 · Cited by 16

Crotonylation of IDH1 alleviates MASLD progression by enhancing the TCA cycle

Liu, S., Ji, Y., Wei, L., Zhang, Y., Zeng, L., Min, Y., Yin, D., Liu, K., Guan, C., Liu, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62731-9 · Cited by 13

Remodeling of Hepatocyte Mitochondrial Metabolism and De Novo Lipogenesis During the Embryonic-to-Neonatal Transition in Chickens

Surugihalli, C., Farley, L. S., Beckford, R. C., Kamkrathok, B., Liu, H., Muralidaran, V., Patel, K., Porter, T. E., & Sunny, N. E. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.870451 · Cited by 13

Dietary Regulation of Hepatic Triacylglycerol Content—the Role of Eucaloric Carbohydrate Restriction with Fat or Protein Replacement

Lundsgaard, A., Bojsen-Møller, K. N., & Kiens, B. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.08.005 · Cited by 14

Quantitative proteomics analysis based on data-independent acquisition reveals the effect of Shenling Baizhu powder (SLP) on protein expression in MAFLD rat liver tissue

Song, S., Zheng, J., Zhao, D., Zheng, A., Zhu, Y., Xu, Q., & Liu, T. (2023) · Clinical Proteomics · doi:10.1186/s12014-023-09442-9 · Cited by 13

Some paradoxes and unresolved aspects of hepatic de novo lipogenesis

Jones, J. G. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00020-7 · Cited by 14

The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease

Acierno, C., Nevola, R., Rinaldi, L., Sasso, F. C., Adinolfi, L. E., & Caturano, A. (2025) · Livers · doi:10.3390/livers5020017 · Cited by 14

Microvesicles Correlated with Components of Metabolic Syndrome in Men with Type 2 Diabetes Mellitus and Lowered Testosterone Levels But Were Unaltered by Testosterone Therapy

Botha, J., Magnussen, L. V., Nielsen, M. H., Nielsen, T. B., Højlund, K., Andersen, M., & Handberg, A. (2017) · Journal of Diabetes Research · doi:10.1155/2017/4257875 · Cited by 13

Enhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope Tracers

Daurio, N. A., Wang, S.-P., Chen, Y., Zhou, H., McLaren, D. G., Roddy, T. P., Johns, D. G., Milot, D. P., Kasumov, T., Erion, M. D., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.241091 · Cited by 13

A simple method to monitor hepatic gluconeogenesis and triglyceride synthesis following oral sugar tolerance test in obese adolescents

Carreau, A., Jin, E. S., Garcia‐Reyes, Y., Rahat, H., Nadeau, K. J., Malloy, C. R., & Cree‐Green, M. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00047.2019 · Cited by 13

Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes

Lee, S., Bae, J., Jo, D. R., Lee, M., Lee, Y., Kang, E. S., Soo, B., & Lee, B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1124576 · Cited by 14

Common Genetic Variants and Nonalcoholic Fatty Liver Disease

Browning, J. D. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.05.013 · Cited by 13

Extraintestinal manifestations of inflammatory bowel disease, nitroxidative stress and dysbiosis: What is the link between them?

Martins, A. S. D. P., Campos, S. B. G., Goulart, M. O. F., Fabiana, & Moura, F. A. (2021) · Biocell · doi:10.32604/biocell.2021.014332 · Cited by 13

Effects of UBE3A on Cell and Liver Metabolism through the Ubiquitination of PDHA1 and ACAT1

Peng, K., Wang, S., Liu, R., Zhou, L., Jeong, G. H., Jeong, I. H., Liu, X., Kiyokawa, H., Xue, B., Zhao, B., et al. (2023) · Biochemistry · doi:10.1021/acs.biochem.2c00624 · Cited by 12

The potential role of glucokinase activator SHP289-04 in anti-diabetes and hepatic protection

Lei, L., Liu, S., Li, Y., Song, H., He, L., Liu, Q., Sun, S., Li, Y., Feng, Z., & Shen, Z. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.02.036 · Cited by 12

Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)

Gallego‐Durán, R., Albillos, A., Ampuero, J., Arechederra, M., Bañares, R., Blas‐García, A., Berná, G., Caparrós, E., Delgado, T. C., Falcón‐Pérez, J. M., et al. (2022) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2022.02.005 · Cited by 13

High-Fructose/High-Fat Diet Downregulates the Hepatic Mitochondrial Oxidative Phosphorylation Pathway in Mice Compared with High-Fat Diet Alone

Morales, M. D. C., Chang, C., Le, V. L., Huang, I., Tsai, I., Shih, H., & Huang, C. (2022) · Cells · doi:10.3390/cells11213425 · Cited by 12

THE CORRELATION OF NECK CIRCUMFERENCE AND INSULIN RESISTANCE IN NAFLD PATIENTS

Boemeke, L., Raimundo, F. V., Bopp, M., Leonhardt, L. R., Fernandes, S. A., & Marroni, C. A. (2019) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.201900000-06 · Cited by 12

The role of nuclear receptors in metabolic homeostasis and disease: From molecular mechanisms to drug discovery

He, F., Wu, H., Zhao, F., Liu, X., Yang, Q., Zhou, S., Xu, T., Xu, J., Wang, S., & Zou, D. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107856 · Cited by 12

Exercise and inactivity as modifiers of β cell function and type 2 diabetes risk

Hall, L. G., Thyfault, J. P., & Johnson, J. D. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00472.2022 · Cited by 15

The metabolic and toxic acute effects of phloretin in the rat liver

da Silva, F. S. I., Bizerra, P. F. V., Mito, M. S., Constantin, R. P., Klosowski, E. M., de Souza, B. T. L., Menezes, P. V. M. D. C., Bueno, P. S. A., Nanami, L. F., Marchiosi, R., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110054 · Cited by 11

Inhibition of lipolysis by ilexgenin A via AMPK activation contributes to the prevention of hepatic insulin resistance

Li, L., Zhang, T., Yang, L., Zhang, L., Wang, L., Liu, B., & Liu, K. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.07.038 · Cited by 11

A hypercaloric diet induces hepatic oxidative stress, infiltration of lymphocytes, and mitochondrial reshuffle in Psammomys obesus, a murine model of insulin resistance

Sihali-Beloui, O., Aroune, D., Benazouz, F., Hadji, A., El-Aoufi, S., & Marco, S. (2019) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2019.04.003 · Cited by 11

Modelling Nonalcoholic Steatohepatitis In Vivo—A Close Transcriptomic Similarity Supports the Guinea Pig Disease Model

Skat‐Rørdam, J., Ipsen, D. H., Seemann, S. E., Latta, M. R., Lykkesfeldt, J., & Tveden‐Nyborg, P. (2021) · Biomedicines · doi:10.3390/biomedicines9091198 · Cited by 11

Adaptation of Oxidative Phosphorylation Machinery Compensates for Hepatic Lipotoxicity in Early Stages of MAFLD

Fahlbusch, P., Nikolic, A., Hartwig, S., Jacob, S., Kettel, U., Koellmer, C., Al‐Hasani, H., Lehr, S., Müller‐Wieland, D., Knebel, B., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126873 · Cited by 11

Slow TCA flux implies low ATP production in tumorsPreprint

Bartman, C., Shen, Y., Lee, W. D., TeSlaa, T. A., Jankowski, C. S. R., Wang, L., Yang, L., Roichman, A., Bhatt, V. D., Lan, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.04.463108 · Cited by 11

The therapeutic mechanisms and beneficial effects of ursodeoxycholic acid in the treatment of nonalcoholic fatty liver disease: a systematic review

Stan, S. I., Biciuşcă, V., Clenciu, D., Mitrea, A., Boldeanu, M. V., Durand, P., & Dănoiu, S. (2023) · Medicine and Pharmacy Reports · doi:10.15386/mpr-2629 · Cited by 14

Detecting altered hepatic lipid oxidation by MRI in an animal model of MASLD

McLeod, M., Chang, M. C., Rushin, A., Ragavan, M., Mahar, R., Sharma, G. K., Badar, A., Giacalone, A., Glanz, M. E., Malut, V. R., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101714 · Cited by 12

Targeted metabolomics reveals bioactive inflammatory mediators from gut into blood circulation in children with NAFLD

Luo, M., Luo, J., Kaminga, A. C., Wei, J., Dai, W., Zhong, Y., Xu, N., Li, X., Zhou, H., & Pan, X. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00706-w · Cited by 10

Elucidating Molecular Mechanisms of Drug-Induced Hepatotoxicity of Lapatinib

Yu, Q., Ma, L., Norona, L. M., Dragovich, P. S., Wang, J., Wang, S., Chen, Y.-C., Khojasteh, S. C., Kenny, J. R., Dean, B. J., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01305 · Cited by 10

Exploring Liver Mitochondrial Function by 13C-Stable Isotope Breath Tests: Implications in Clinical Biochemistry

Grattagliano, I., Bonfrate, L., Lorusso, M. P., Castorani, L., de Bari, O., & Portincasa, P. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1875-1_12 · Cited by 10

Liver-Brain Axis in Sporadic Alzheimer’s Disease: Role of Ten Signature Genes in a Mouse Model

Jakhmola-Mani, R., Islam, A., & Katare, D. P. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666201209111006 · Cited by 10

Association of plasma metabolites and diagnostic imaging findings with hepatic lipidosis in bearded dragons (Pogona vitticeps) and effects of gemfibrozil therapy

Barboza, T. K., Susta, L., Linden, A. Z., Gardhouse, S. M., & Beaufrère, H. (2023) · PLoS ONE · doi:10.1371/journal.pone.0274060 · Cited by 12

Investigation of Obesity-Alleviation Effect of Eurycoma longifolia on Mice Fed with a High-Fat Diet through Metabolomics Revealed Enhanced Decomposition and Inhibition of Accumulation of Lipids

Zhang, D., Zheng, W. L., Li, X., Ge, L., Ye, N., Liu, Y., Li, A., Liu, X., Zhang, R., Cheng, J., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00015 · Cited by 10

Dietary Macronutrient Composition Differentially Modulates the Remodeling of Mitochondrial Oxidative Metabolism during NAFLD

Kattapuram, N., Zhang, C., Muyyarikkandy, M. S., Surugihalli, C., Muralidaran, V., Gregory, T., & Sunny, N. E. (2021) · Metabolites · doi:10.3390/metabo11050272 · Cited by 10

Loss of ovarian function prevents exercise-induced activation of hepatic mitophagic flux

Franczak, E., Kugler, B. A., Salathe, S. F., Allen, J., Sardiu, M. E., McCoin, C. S., Hevener, A. L., Morris, E. M., & Thyfault, J. P. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00107.2025 · Cited by 9

Insights into mouse metabolic health and gut microbiota responses to conventional and biodegradable microplastics released from plastic food containers

Cui, H., Zhang, R., Huang, J., Kong, C., Yao, C., & Jin, Z. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.139652 · Cited by 10

Metabolic drivers of MASLD and MASH: from hormonal imbalance to fibrosis

Gastaldelli, A., Scoditti, E., & Macedo, M. P. (2026) · Diabetologia · doi:10.1007/s00125-026-06774-7 · Cited by 11

Influence of plasma macronutrient levels on hepatic metabolism: role of regulatory networks in homeostasis and disease states

Somvanshi, P. R., Patel, A. K., Bhartiya, S., & Venkatesh, K. V. (2016) · RSC Advances · doi:10.1039/c5ra18128c · Cited by 9

Mapping Lipogenic Flux: A Gold LDI–MS Approach for Imaging Neutral Lipid Kinetics

Downes, D. P., Zhong, W., Zhang, J., Chen, B., Satapati, S., Metzger, D., Godinez, G. L., Lao, J. Z., Sheth, P. R., McLaren, D. G., et al. (2020) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.0c00199 · Cited by 9

Cisd2 Preserves the Youthful Pattern of the Liver Proteome during Natural Aging of Mice

Huang, C., Huang, Y., Shen, Z., Lin, C., & Tsai, T. (2021) · Biomedicines · doi:10.3390/biomedicines9091229 · Cited by 9

Serum metabolomics-based heterogeneities and screening strategy for metabolic dysfunction-associated fatty liver disease (MAFLD)

Shao, L., Liu, J., Song, Y., Yang, W., Gong, L., Lyu, Z., Zhu, Q., Fu, J., Li, J., & Shi, J. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.12.014 · Cited by 10

Prevalence and Influence Factors for Non-Alcoholic Fatty Liver Disease in Long-Term Hospitalized Patients with Schizophrenia: A Cross-Sectional Retrospective Study

Li, X., Gao, Y., Wang, Y., Wang, Y., & Wu, Q. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s398385 · Cited by 12

Effects of liver function, insulin resistance and inflammatory factors on vascular endothelial dilation function and prognosis of coronary heart disease patients complicated with NAFLD

Wang, B., Li, F., Guo, J., Wang, C., Xu, D., & Li, C. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7043 · Cited by 9

Syncytialization and prolonged exposure to palmitate impacts BeWo respiration

Easton, Z. J. W., Delhaes, F., Mathers, K. E., Zhao, L., Vanderboor, C., & Regnault, T. R. H. (2020) · Reproduction · doi:10.1530/rep-19-0433 · Cited by 8

A high-protein diet is anti-steatotic and has no pro-inflammatory side effects in dyslipidaemic APOE2 knock-in mice

Garcia‐Caraballo, S., Comhair, T. M., Dejong, C. H. C., Lamers, W. H., & Köhler, E. S. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514001986 · Cited by 9

Role of oxidative stress, gut microbiota and derived metabolites in the etiology and progression of nonalcoholic fatty liver disease

Das, A., De, A. J., Mohanty, T., & Aich, P. (2023) · Redox Experimental Medicine · doi:10.1530/rem-23-0016 · Cited by 10

The impact of solute carrier proteins on disrupting substance regulation in metabolic disorders: insights and clinical applications

Du, J., Shen, M., Chen, J., Yan, H., Xu, Z., Yang, X., Yang, B., Luo, P., Ding, K., Hu, Y., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1510080 · Cited by 9

Metabolomic profiling of Wilson disease, an inherited disorder of copper metabolism, and diseases with similar symptoms but normal copper metabolism

Qiu, Y., Su, M., Xiao, X., Zhou, D., & Xie, L. (2023) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-023-02900-5 · Cited by 8

Response to Burgess

Befroy, D. E., Kibbey, R. G., Perry, R. J., Petersen, K. F., Rothman, D. L., & Shulman, G. I. (2015) · Nature Medicine · doi:10.1038/nm.3790 · Cited by 8

Non-alcoholic fatty liver disease: more than just ectopic fat accumulation

Francisco Barrera, M., & George, J. (2013) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2013.06.002 · Cited by 8

Pathogenesis of NAFLD and NASH

Maher, J. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-20538-0_4 · Cited by 8

Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet

Carril, E., Valdecantos, M. P., Lanzón, B., Angulo, S., Valverde, Á. M., Godzień, J., & Rupérez, F. J. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.112958 · Cited by 8

Insulin-stimulated lipogenesis gets an epigenetic makeover

Manuel, C. R., & Haeusler, R. A. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137050 · Cited by 8

Adeno-Associated Virus-Mediated Knockdown of SLC16A11 Improves Glucose Tolerance and Hepatic Insulin Signaling in High Fat Diet-Fed Mice

Zhang, T., Qi, Z., Wang, H., & Ding, S. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0840-3330 · Cited by 9

Where does liver fat go? A possible molecular link between fatty liver and diabetes

Kikuchi, A., & Takamura, T. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12573 · Cited by 8

Biochemical basis and therapeutic potential of mitochondrial uncoupling in cardiometabolic syndrome

dos Santos, B. G., Brisnovali, N. F., & Goedeke, L. (2024) · Biochemical Journal · doi:10.1042/bcj20240005 · Cited by 7

FXR adapts hepatic mitochondrial function to increased substrate oxidation in patients with obesity

Panzitt, K., Jungwirth, E., Vosko, L. E., Madreiter‐Sokolowski, C. T., Madl, T., Tawfik, I., Habisch, H., Krstić, J., Prokesch, A., Karitnig, R., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adn4558 · Cited by 7

Effects of dietary fibres on gut microbial metabolites and liver lipid metabolism in growing pigs

Hu, Y., Chen, D., Yu, B., Yan, H., Zheng, P., Mao, X., Yu, J., He, J., Huang, Z., Luo, Y., et al. (2020) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13429 · Cited by 7

Measurement of the Concentration of Citrate in Human Biofluids in Patients Undergoing Continuous Renal Replacement Therapy Using Regional Citrate Anticoagulation: Application of a Two-Step Enzymatic Assay

Anstey, C., & Russell, F. D. (2021) · Blood Purification · doi:10.1159/000513150 · Cited by 7

Assessment of SENP3-interacting proteins in hepatocytes treated with diethylnitrosamine by BioID assay

Chen, F., Yan, H., Guo, C. W., Zhu, H., Yi, J., Sun, X., & Yang, J. (2021) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmab096 · Cited by 7

Mitochondrial respiratory chain activity is associated with severity, corticosteroid response and prognosis of alcoholic hepatitis

Solís‐Muñoz, P., de la Flor‐Robledo, M., García‐Ruíz, I., Fernández-García, C. E., González‐Rodríguez, Á., Shah, N. K., Bataller, R. A., Heneghan, M. A., García‐Monzón, C., & Solis-Herruzo, J. A. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17434 · Cited by 7

Medium-Chain Fatty Acid Feeding Reduces Oxidation and Causes Panacinar Steatosis in Livers of Neonatal Pigs

Gerrard, S. D., Yonke, J. A., McMillan, R. P., Sunny, N. E., & El‐Kadi, S. W. (2024) · Journal of Nutrition · doi:10.1016/j.tjnut.2024.01.023 · Cited by 7

The odd-carbon medium-chain fatty triglyceride triheptanoin does not reduce hepatic steatosis

Comhair, T. M., Garcia‐Caraballo, S., Dejong, C. H. C., Lamers, W. H., & Köhler, E. S. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.11.005 · Cited by 7

Advances in Stable Isotope Tracer Methodology Part 1: Hepatic Metabolism via Isotopomer Analysis and Postprandial Lipolysis Modeling

Behn, C. D., Jin, E. S., Bubar, K. M., Malloy, C. R., Parks, E. J., & Cree‐Green, M. (2019) · Journal of Investigative Medicine · doi:10.1136/jim-2019-001109 · Cited by 7

Beta vulgaris L. beetroot protects against iron-induced liver injury by restoring antioxidant pathways and regulating cellular functions

Ojo, O. A., Adeyemo, T. R., Iyobhebhe, M. E., Adams, M. D., Asaleye, R. M., Evbuomwan, I. O., Abdurrahman, J., Maduakolam-Aniobi, T. C., Nwonuma, C. O., Odesanmi, O. E., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-77503-6 · Cited by 8

Disrupted metabolic flux balance between pyruvate dehydrogenase and pyruvate carboxylase in human fatty liver

Park, J. M., Lin, S., Baxter, J. D., Harrison, C. E., Leary, J., Mozingo, C., Liticker, J., Malloy, C. R., & Jin, E. S. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156151 · Cited by 6

Cgref1 is a CREB-H-regulated hepatokine that promotes hepatic de novo lipogenesis by mediating epididymal fat insulin resistance

Chan, P., Cheung, P. H., Kang, X.-Z., Cheng, Y., Wong, C., Jin, D., & Chan, C. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.97008 · Cited by 6

NMR‐Based Metabolomics Reveals Metabolic Pathway Disruptions and Potential Biomarkers for Fibrosis

Pandey, S., Marwari, D., Mishra, J., Goel, A., Mishra, A. K., & Sinha, N. (2025) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.70017 · Cited by 6

Plasma and fecal bile acids profiles in metabolic dysfunction-associated steatotic liver disease with advanced fibrosis

Pradeau, M., Beaulieu, S., Paquet, V., Trottier, J., Verreault, M., Ferland, S., Barbier, O., & Carreau, A. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00346.2024 · Cited by 10

Activin receptor type IIA/IIB blockade increases muscle mass and strength, but compromises glycemic control in mice

Carlsson, M., Frank, E., Màrmol, J. M., Ali, M. S., Raun, S. H., Battey, E., Andersen, N. R., Irazoki, A., Lund, C., Henríquez‐Olguín, C., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102261 · Cited by 6

Complex I Modulator BI4500 Reduces MASH by Limiting Oxidative Stress and Reprogramming Lipid Metabolism via AMPK in MCD Rats

Pasqua, L. G. D., Lotti, S., Trucchi, M., Palladini, G., Croce, A. C., Protopapa, F., Feletti, F., Kauschke, S. G., Sun, P., Vairetti, M., et al. (2026) · Antioxidants · doi:10.3390/antiox15010082 · Cited by 6

Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i

Harada, M., Adam, J., Covic, M., Ge, J., Brandmaier, S., Muschet, C., Huang, J., Han, S., Rommel, M., Rotter, M., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02288-x · Cited by 6

The primate gut microbiota contributes to interspecific differences in host metabolism

Mallott, E. K., Kuthyar, S., Lee, W., Reiman, D. J., Jiang, H., Chitta, S., Waters, E. A., Layden, B. T., Sumagin, R., Manzanares, L. D., et al. (2024) · Microbial Genomics · doi:10.1099/mgen.0.001322 · Cited by 10

Amino Acid and Fatty Acid Levels Affect Hepatic Phosphorus Metabolite Content in Metabolically Healthy Humans

KAHL, S., Nowotny, B., Straßburger, K., Bierwagen, A., Klüppelholz, B., Hoffmann, B. H., Giani, G., Nowotny, P., Wallscheid, F., Hatziagelaki, E. E., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01773 · Cited by 6

Macronutrient, Energy, and Bile Acid Metabolism Pathways Altered Following a Physiological Meal Challenge, Relative to Fasting, among Guatemalan Adults

Yu, E. A., Yu, T., Jones, D. P., Martorell, R., Ramírez‐Zea, M., & Stein, A. D. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa169 · Cited by 8

In Vivo and In Vitro Quantification of Glucose Kinetics: From Bedside to Bench

Kim, I., Park, S., Kim, Y., Chang, Y., Choi, C. S., Suh, S., & Wolfe, R. R. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.406 · Cited by 6

Macronutrient Modulation in Metabolic Dysfunction-Associated Steatotic Liver Disease—the Molecular Role of Fatty Acids compared with Sugars in Human Metabolism and Disease Progression

Mullin, S. M., Kelly, A. J., Chathail, M. B. N., Norris, S., Shannon, C. E., & Roche, H. M. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100375 · Cited by 10

Induction of Fructose Mediated De Novo Lipogenesis Coexists with the Upregulation of Mitochondrial Oxidative Function in Mice Livers

Bhattacharjee, P., Fadlaoui, A., Ryan, C. E., Carlson, C. B., Zhang, D., & Sunny, N. E. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.04.030 · Cited by 5

A prolonged fast improves overnight substrate oxidation without modulating hepatic glycogen in adults with and without nonalcoholic fatty liver: A randomized crossover trial

Roumans, K. H. M., Veelen, A., Andriessen, C., Mevenkamp, J., Moonen‐Kornips, E., Veeraiah, P., Havekes, B., Peters, H. P. F., Lindeboom, L., Schrauwen, P., et al. (2023) · Obesity · doi:10.1002/oby.23676 · Cited by 5

The neglected PCK1/glucagon (inter)action in nutrient homeostasis beyond gluconeogenesis: Disease pathogenesis and treatment

Bertinat, R., Holyoak, T., Gatica, R., Jara, N., González‐Chavarría, I., & Westermeier, F. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102112 · Cited by 5

Activation of SIK2 inhibits gluconeogenesis and alleviates lipogenesis‐induced inflammatory response by SIK2 ‐ CRTC2 ‐ ACC1 in hepatocytes of large yellow croaker ( Larimichthys crocea )

Han, S., Xiang, X., Zhang, X., Ou, L., Liu, Q., Xu, X., Zhang, J., Hao, T., Du, J., Li, Y., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202402628r · Cited by 5

Simultaneous in vivo multi-organ fluxomics reveals divergent metabolic adaptations in liver, heart, and skeletal muscle during obesity

Rahim, M., Bednarski, T. K., Hasenour, C. M., Banerjee, D. R., Trenary, I. A., & Young, J. D. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115591 · Cited by 5

Inhibitory Effects of Anthocyanin-rich Fraction from Purple Sweet Potato on High Fat Diet-induced Insulin Resistance and Hepatic Steatosis

Nam, S. Y., Jang, H., Kim, J. B., Lee, S. H., & Lee, Y. M. (2016) · Journal of the East Asian Society of Dietary Life · doi:10.17495/easdl.2016.6.26.3.278 · Cited by 5

Investigating the Protective Effects of a Rhenium (V) Compound with Uracil-Derived Ligands on Liver Damage Associated with Prediabetes in Diet-Induced Prediabetic Rats

Siboto, A., Akinnuga, A. M., Ismail, M. B., Booysen, I. N., Sibiya, N. H., Ngubane, P. S., & Khathi, A. (2022) · Diabetology · doi:10.3390/diabetology3040040 · Cited by 5

Adherence to low carbohydrate diets and non-alcoholic fatty liver disease: a case control study

Yaghoubi, F., Darand, M., Vasmehjani, A. A., Darabi, Z., Talenezhad, N., Mirzavandi, F., & Hosseinzadeh, M. (2022) · BMC Nutrition · doi:10.1186/s40795-022-00625-5 · Cited by 4

Oleic acid induces the novel apolipoprotein O and reduces mitochondrial membrane potential in chicken and human hepatoma cells

Weijler, A. M., Schmidinger, B., Kapiotis, S., Laggner, H., & Hermann, M. (2018) · Biochimie · doi:10.1016/j.biochi.2018.02.003 · Cited by 5

Mitochondrial pathways in NAFLD

Koch, L. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.240 · Cited by 2

Induction of Mitochondrial Tri‐carboxylic Acid Cycle is Sustained in Mice with Nonalcoholic Steatohepatitis (NASH)

Kalavalapalli, S., Patterson, R. E., Nautiyal, M., Mathew, J. T., Martinez, J., Garrett, T. J., Cusi, K. J., & Sunny, N. E. (2015) · The FASEB Journal · doi:10.1096/fasebj.29.1_supplement.258.4

Assessment of Hepatic Mitochondrial Oxidation and Pyruvate Cycling in NAFLD by 13C Magnetic Resonance Spectroscopy

Petersen, K. F., Befroy, D. E., Dufour, S., Rothman, D. L., & Shulman, G. I. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.005 · Cited by 86

Impact of sustained de novo lipogenesis on mitochondrial dysfunction and hepatocellular redox during fatty liver disease

Bhattacharjee, P., Carlson, C., Ryan, C. E., Fadlaoui, A., & Sunny, N. E. (2023) · Physiology · doi:10.1152/physiol.2023.38.s1.5730204 · Cited by 1

Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver

Satapati, S., Kucejová, B., Duarte, J. A. G., Fletcher, J. A., Reynolds, L., Sunny, N. E., He, T., Nair, L. A., Livingston, K. A., Fu, X., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82204 · Cited by 403